» Articles » PMID: 17234578

The Cationic Amino Acid Transporters CAT1 and CAT3 Mediate NMDA Receptor Activation-dependent Changes in Elaboration of Neuronal Processes Via the Mammalian Target of Rapamycin MTOR Pathway

Overview
Journal J Neurosci
Specialty Neurology
Date 2007 Jan 20
PMID 17234578
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronal activity influences protein synthesis and neuronal growth. Availability of nutrients, especially leucine and arginine, regulates the mammalian target of rapamycin (mTOR) pathway that controls cell growth. We show that NMDA receptor activation markedly reduces arginine transport by decreasing surface expression of the cationic amino acid transporters (CAT) 1 and 3. Depletion of CAT1 and CAT3 by RNA interference blocks influences of NMDA receptor activation on the mTOR pathway and neuronal process formation. Thus, the CATs mediate influences of NMDA receptor activation on the mTOR pathway that regulates neuronal processes.

Citing Articles

Investigation of molecular details of a bacterial cationic amino acid transporter (GkApcT) during arginine transportation using molecular dynamics simulation and umbrella sampling techniques.

Afshinpour M, Parsi P, Mahdiuni H J Mol Model. 2023; 29(8):260.

PMID: 37479900 DOI: 10.1007/s00894-023-05670-w.


Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy.

Yang L, Chu Z, Liu M, Zou Q, Li J, Liu Q J Hematol Oncol. 2023; 16(1):59.

PMID: 37277776 PMC: 10240810. DOI: 10.1186/s13045-023-01453-1.


NRF3 activates mTORC1 arginine-dependently for cancer cell viability.

Hirose S, Waku T, Tani M, Masuda H, Endo K, Ashitani S iScience. 2023; 26(2):106045.

PMID: 36818298 PMC: 9932127. DOI: 10.1016/j.isci.2023.106045.


NMDA Receptor and Its Emerging Role in Cancer.

Gallo S, Vitacolonna A, Crepaldi T Int J Mol Sci. 2023; 24(3).

PMID: 36768862 PMC: 9917092. DOI: 10.3390/ijms24032540.


Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).

Huttunen J, Adla S, Markowicz-Piasecka M, Huttunen K Pharmaceutics. 2022; 14(6).

PMID: 35745806 PMC: 9228667. DOI: 10.3390/pharmaceutics14061234.


References
1.
Montagne J, Stewart M, Stocker H, Hafen E, Kozma S, Thomas G . Drosophila S6 kinase: a regulator of cell size. Science. 1999; 285(5436):2126-9. DOI: 10.1126/science.285.5436.2126. View

2.
Kumar V, Pandey P, Sabatini D, Kumar M, Majumder P, Bharti A . Functional interaction between RAFT1/FRAP/mTOR and protein kinase cdelta in the regulation of cap-dependent initiation of translation. EMBO J. 2000; 19(5):1087-97. PMC: 305647. DOI: 10.1093/emboj/19.5.1087. View

3.
Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E . Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 2000; 14(21):2689-94. PMC: 317036. DOI: 10.1101/gad.845700. View

4.
Zhang H, Stallock J, Ng J, Reinhard C, Neufeld T . Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 2000; 14(21):2712-24. PMC: 317034. DOI: 10.1101/gad.835000. View

5.
Nicholson B, Manner C, Kleeman J, Macleod C . Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem. 2001; 276(19):15881-5. DOI: 10.1074/jbc.M010030200. View